NCT05058313View on ClinicalTrials.gov

Evaluation of the Safety and Performance of the MILTA GYNECO Vaginal Probe in Postmenopausal Women With Vaginal Atrophy

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 29, 2022

Primary Completion Date

June 13, 2023

Study Completion Date

May 6, 2024

Conditions
MenopauseUrinary IncontinenceAtrophic Vaginitis
Interventions
DEVICE

Photobiomodulation

Six weekly photobiomodulation sessions (PBMT) using the MILTA ™ GYNECO vaginal probe.

Trial Locations (3)

59322

Centre Hospitalier de Valenciennes, Valenciennes

Unknown

CHU Nîmes, Nîmes

Centre Médical KARIS, Perpignan

All Listed Sponsors
collaborator

PHYSIOQUANTA

UNKNOWN

lead

Centre Hospitalier Universitaire de Nīmes

OTHER